Puma Investors' Suit Lives As Judge Dings Judicial Notice
Puma Biotechnology Inc. will have to face a proposed class action for allegedly misleading investors about a breast cancer drug, a California federal judge ruled in an order Friday that also...To view the full article, register now.
Already a subscriber? Click here to view full article